AbQader Bedil: Donor Ferritin Testing and Iron Care
AbQader Bedil, Medical Laboratory Technologist at French Medical Institute for Mothers and Children- FMIC, Laboratory Incharge at Stanikza Diagnostic clinic, shared a post on LinkedIn:
”Donor Ferritin Testing and Iron Care
Blood donation is generous — but repeated donations quietly drain iron stores. Measuring serum ferritin (not just hemoglobin) is the fastest way to spot iron depletion and act before donors develop symptoms or get deferred. Practical ferritin programs now show you can protect donors and keep the supply stable.
Quick facts:
- Many blood operators now add selective or routine ferritin testing to their donor-wellness programs to identify donors at risk of iron deficiency.
- Expert reviews and working groups recommend ferritin-guided policies (testing, tailored donation intervals, and iron supplementation) as the best way to prevent iron depletion in frequent donors.
- Recent trials show ferritin-guided donation intervals or ferritin-based supplementation significantly raise donors’ ferritin and hemoglobin and reduce iron-deferral rates.
What a practical ferritin program looks like:
- Decide scope: pilot high-risk groups first (premenopausal females, young donors, repeat donors), then expand if capacity allows.
- Pick action thresholds: many programs flag ferritin ≲25 µg/L for intervention (deferred interval or iron offer), but define locally with lab vendors and clinical leads.
- Define actions: short donor pause (eg, 3–6 months), offer oral iron with instructions, or schedule follow-up ferritin testing. Put the action in SOPs and donor letters.
- Measure outcomes: track percent low-ferritin donors, donor return rates, iron-related deferrals, and the program’s effect on supply — iterate from data.
Why this matters:
Ferritin testing is donor-centred and evidence-based: it prevents iron deficiency, reduces unexpected deferrals, and keeps more healthy donors in the pool — that’s a win for donors and patients.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation